 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study |
| Ju Hwan Kim, Yeon-Hee Baek, Hyesung Lee, Young June Choe, Hyun Joon Shin, Ju-Young Shin |
|
Epidemiol Health. 2021;43:e2021004 Published online December 29, 2020 DOI: https://doi.org/10.4178/epih.e2021004 |
|
End-stage renal disease and adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among patients with diabetes The Journal of Clinical Hypertension. 2017;19(6):627-631  A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers European Heart Journal - Cardiovascular Pharmacotherapy. 2020;7(2):148-157 Angiotensin-converting enzyme inhibitors (ACEI) or Angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients . 2020; Angiotensin-Converting Enzyme Inhibitors (ACEI) or Angiotensin Receptor Blockers (ARBs) May Be Safe for COVID-19 Patients . 2020; A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers Therapeutics and Clinical Risk Management. 2009;547 Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in African‐American Patients With Hypertension The Journal of Clinical Hypertension. 2004;6(6):310-314 Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? Clinical Science. 2021;135(8):1009-1014 Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(4):349-350 Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Encyclopedia of Heart Diseases. 2006;61-67 Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19 Journal of Travel Medicine. 2020;27(3): |
